Abstract
Tuberculosis is one of the leading causes of morbidity and mortality worldwide. Current treatment has several challenges, such as multi-drug resistance, extensively drug-resistance and HIV co-infection. Problems related to patients, treatment and health care system also contribute negatively to this panel. This review summarizes the main obstacles causing in the treatment of tuberculosis and discusses several strategies to improve the treatment.
Keywords: Drug interactions, extensively drug-resistance, HIV, multi-drug resistance, treatment improvement, tuberculosis, tuberculosis treatment.
Current Clinical Pharmacology
Title:Tuberculosis: Challenges to Improve the Treatment
Volume: 10 Issue: 3
Author(s): Mariana Moreira Lima, Ariane Trindade, Flávia Carnavalli, Aylime Castanho Bolognesi Melchior, Chung Man Chin and Jean Leandro dos Santos
Affiliation:
Keywords: Drug interactions, extensively drug-resistance, HIV, multi-drug resistance, treatment improvement, tuberculosis, tuberculosis treatment.
Abstract: Tuberculosis is one of the leading causes of morbidity and mortality worldwide. Current treatment has several challenges, such as multi-drug resistance, extensively drug-resistance and HIV co-infection. Problems related to patients, treatment and health care system also contribute negatively to this panel. This review summarizes the main obstacles causing in the treatment of tuberculosis and discusses several strategies to improve the treatment.
Export Options
About this article
Cite this article as:
Lima Moreira Mariana, Trindade Ariane, Carnavalli Flávia, Bolognesi Melchior Castanho Aylime, Chin Man Chung and dos Santos Leandro Jean, Tuberculosis: Challenges to Improve the Treatment, Current Clinical Pharmacology 2015; 10 (3) . https://dx.doi.org/10.2174/1574884708666131229124215
DOI https://dx.doi.org/10.2174/1574884708666131229124215 |
Print ISSN 1574-8847 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3938 |
Related Articles
-
Therapeutic and Protective Potential of Mesenchymal Stem Cells, Pharmaceutical
Agents and Current Vaccines Against COVID-19
Current Stem Cell Research & Therapy Molecular Modeling Investigation of Some New 2-mercaptoimidazoles
Current Computer-Aided Drug Design Development and Implementation of the DHAPP Military eHealth Information Network System
Current HIV Research In Silico Methods for Predicting Ligand Binding Determinants of Cytochromes P450
Current Topics in Medicinal Chemistry Patent Selections
Recent Patents on Anti-Infective Drug Discovery The Inhibition of 5-enolpyruvylshikimate-3-phosphate Synthase as a Model for Development of Novel Antimicrobials
Current Drug Targets HIV-Tuberculous Meningitis Co-Infection: A Systematic Review and Meta-Analysis
Current Pharmaceutical Biotechnology Synthesis and Evaluation of New Thiazole Derivatives as Potential Antimicrobial Agents
Letters in Drug Design & Discovery Application of Computational Techniques to Unravel Structure-Function Relationship and their Role in Therapeutic Development
Current Topics in Medicinal Chemistry Synthesis, Spectroscopic, In-vitro and Computational Analysis of Hydrazones as Potential Antituberculosis Agents: (Part-I)
Combinatorial Chemistry & High Throughput Screening Targeting Intracellular Targets
Current Drug Delivery Therapeutic Potential of Natural Products from Terrestrial Plants as TNF-α Antagonist
Current Topics in Medicinal Chemistry Contrast Enhanced Sonography for Diagnosis of (Peri-) Splenic Pathology
Current Medical Imaging ITK Inhibitors in Inflammation and Immune-Mediated Disorders
Current Topics in Medicinal Chemistry Secretory Leukocyte Protease Inhibitor: More than Just A Protease Inhibitor
Current Immunology Reviews (Discontinued) Drug Carriers in Pharmaceutical Design: Promises and Progress
Current Pharmaceutical Design Targeting Tumor Necrosis Factor-α in the Therapy of Psoriasis
Current Drug Targets - Inflammation & Allergy Synthesis of Imidazo[1,2-b]pyridazine Comprised Piperazine, Morpholine Derivatives as Potent Antimycobacterial Agents with In Vivo Locomotor Activity
Anti-Infective Agents Crystal Engineering to Design of Solids: From Single to Multicomponent Organic Materials
Mini-Reviews in Organic Chemistry Potential Strategies for Minimizing Mechanism-Based Inhibition of Cytochrome P450 3A4
Current Pharmaceutical Design